Isabelle Radford-Weiss Selected Research

Isabelle Radford-Weiss Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 06/2002
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2004
5	Leukemia 01/2016 - 03/2007
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016 - 11/2006
3	Lymphoma (Lymphomas) 01/2021 - 05/2004
2	Genetic Translocation (Chromosomal Translocation) 01/2016 - 05/2013
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2012 - 08/2003
1	Oncogene Addiction 01/2022
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2020
1	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 12/2019
1	Hemolysis 10/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2017
1	T-Cell Leukemia (Leukemia, T Cell) 04/2014
1	Infections 04/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2013
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 06/2013
1	Celiac Disease (Celiac Sprue) 12/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2012
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2011
1	Autoimmune Lymphoproliferative Syndrome 01/2011
1	Pancytopenia 04/2010
1	Acute Promyelocytic Leukemia 04/2010
1	Hematologic Neoplasms (Hematological Malignancy) 03/2007
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2004
1	Trisomy (Trisomies) 05/2004
1	Adenocarcinoma 05/2004

Drug/Important Bio-Agent (IBA)

5	Biological ProductsIBA 01/2021 - 01/2009
4	Proteins (Proteins, Gene)FDA Link 11/2013 - 08/2003
2	IronIBA 10/2017 - 04/2010
2	nuclear pore complex protein 98IBA 01/2016 - 03/2012
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2013 - 11/2006
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2011 - 11/2004
2	Death Domain ReceptorsIBA 01/2011 - 11/2004
1	trametinibIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Intergenic DNA (Junk DNA)IBA 01/2022
1	Cyclin-Dependent Kinase 6IBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2016
1	AntibodiesIBA 04/2014
1	Interleukin-10 (Interleukin 10)IBA 11/2013
1	Interleukin-10 ReceptorsIBA 11/2013
1	Glutamine (L-Glutamine)FDA Link 11/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2013
1	TOR Serine-Threonine KinasesIBA 11/2013
1	Sorafenib (BAY 43-9006)FDA Link 06/2013
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 03/2012
1	Iron Chelating AgentsIBA 04/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2010
1	Mitogen-Activated Protein KinasesIBA 04/2010
1	Arsenic Trioxide (Trisenox)FDA Link 04/2010
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2010
1	Transcription Factors (Transcription Factor)IBA 04/2007
1	Janus Kinase 2IBA 03/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2007
1	LigandsIBA 11/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2004
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 11/2004
1	Cytokine Receptors (Cytokine Receptor)IBA 06/2004
1	AcidsIBA 05/2004
1	CD7 AntigensIBA 05/2004
1	RetinoidsIBA 05/2004
1	CD56 AntigenIBA 06/2002

Therapy/Procedure

6	Therapeutics 01/2022 - 04/2010
3	Drug Therapy (Chemotherapy) 12/2020 - 11/2004
3	Stem Cell Transplantation 12/2019 - 06/2004
1	Transplantation 01/2022
1	Heterologous Transplantation (Xenotransplantation) 11/2013
1	Gluten-Free Diet 12/2012
1	Induction Chemotherapy 11/2004
1	Aftercare (After-Treatment) 05/2004